查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356800

影像生物标记市场报告：2030 年趋势、预测与竞争分析

Imaging Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

成像生物标记趋势和预测

预计到 2030 年，全球成像生物标记市场将达到约 177 亿美元，2024 年至 2030 年的年复合成长率为 14.6%。该市场的主要促进因素是慢性病例数量的增加、成像生物标记虚拟和巨量资料技术等技术突破以及全球医疗保健意愿的增强。全球影像生物标记市场的未来充满希望，在个人化医疗、药物研发开拓、分子诊断、药物配方、疾病诊断和法医学市场方面存在机会。

成像生物标誌物市场洞察

Lucintel 预测，磁振造影在预测期内将继续成为最大的细分市场，因为它有助于检测脊髓病变、癌症、血管疾病和脑部疾病。

疾病诊断将继续成为最大的细分市场，因为它能够对新药达到预期目标的患者群体进行表征。

由于人们对该疾病的认识不断提高以及技术进步不断进步，北美在预测期内可能仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球成像生物标记市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球成像生物标记市场趋势（2018-2023）与预测（2024-2030）
  • 按技术分類的全球成像生物标记市场
    • 正子断层扫描
    • 超音波
    • 磁振造影
    • CT检查
    • 单光子发射电脑断层扫描
    • 其他的
  • 按应用分類的全球成像生物标记市场
    • 个人化医疗
    • 药物研发发现与开发
    • 分子诊断
    • 药物製剂
    • 疾病诊断
    • 法医应用
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球成像生物标记市场（按地区）
  • 北美影像生物标记市场
  • 欧洲影像生物标记市场
  • 亚太地区成像生物标记市场
  • 其他区域成像生物标记市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球成像生物标记市场成长机会（按技术）
    • 全球成像生物标记市场成长机会（按应用）
    • 按地区分類的全球成像生物标记市场成长机会
  • 全球成像生物标记市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球成像生物标记市场的产能
    • 全球成像生物标记市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX
简介目录

Imaging Biomarker Trends and Forecast

The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

A more than 150-page report is developed to help in your business decisions.

Imaging Biomarker by Segment

The study includes a forecast for the global imaging biomarker by technology, application, and region.

Imaging Biomarker Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Positron Emission Tomography
  • Ultrasound
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Single-Photon Emission Computed Tomography
  • Others

Imaging Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Personalized Medicines
  • Drug Discovery and Development
  • Molecular Diagnostics
  • Drug Formulation
  • Disease Diagnosis
  • Forensic Applications
  • Others

Imaging Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Imaging Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies imaging biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the imaging biomarker companies profiled in this report include-

  • Siemens Healthineers
  • Icon
  • Invicro
  • Median Technologies
  • Pi Solutions
  • Ixico
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • Brainomix

Imaging Biomarker Market Insights

Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Disease diagnosis will remain the largest segment due to their ability to enable the characterization of patient populations to which new drugs reach intended targets.

North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Features of the Global Imaging Biomarker Market

Market Size Estimates: Imaging biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Imaging biomarker market size by technology, application, and region. in terms of value ($B).

Regional Analysis: Imaging biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, and region.s for the imaging biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the imaging biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the imaging biomarker market size?

Answer: The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030.

Q.2. What is the growth forecast for imaging biomarker market?

Answer: The global imaging biomarker market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the imaging biomarker market?

Answer: The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

Q.4. What are the major segments for imaging biomarker market?

Answer: The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets.

Q.5. Who are the key imaging biomarker market companies?

Answer: Some of the key imaging biomarker companies are as follows:

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX

Q.6. Which imaging biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Q.7. In imaging biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the imaging biomarker market by technology (positron emission tomography, ultrasound, magnetic resonance imaging,computed tomography, single-photon emission computed tomography, and others) application (personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis, forensic applications, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Imaging Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Imaging Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Imaging Biomarker Market by Technology
    • 3.3.1: Positron Emission Tomography
    • 3.3.2: Ultrasound
    • 3.3.3: Magnetic Resonance Imaging
    • 3.3.4: Computed Tomography
    • 3.3.5: Single-Photon Emission Computed Tomography
    • 3.3.6: Others
  • 3.4: Global Imaging Biomarker Market by Application
    • 3.4.1: Personalized Medicines
    • 3.4.2: Drug Discovery and Development
    • 3.4.3: Molecular Diagnostics
    • 3.4.4: Drug Formulation
    • 3.4.5: Disease Diagnosis
    • 3.4.6: Forensic Applications
    • 3.4.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Imaging Biomarker Market by Region
  • 4.2: North American Imaging Biomarker Market
    • 4.2.2: North American Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.3: European Imaging Biomarker Market
    • 4.3.1: European Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.3.2: European Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.4: APAC Imaging Biomarker Market
    • 4.4.1: APAC Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.4.2: APAC Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.5: ROW Imaging Biomarker Market
    • 4.5.1: ROW Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.5.2: ROW Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Othersers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Imaging Biomarker Market by Technology
    • 6.1.2: Growth Opportunities for the Global Imaging Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Imaging Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Imaging Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Imaging Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Imaging Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: ICON
  • 7.3: Invicro
  • 7.4: Median Technologies
  • 7.5: PI Solutions
  • 7.6: IXICO
  • 7.7: Bioxydyn
  • 7.8: Zionexa
  • 7.9: Imabiotech
  • 7.10: BRAINOMIX